Acerca de

Program

08.45-09.20

09.20-09.30

09.30-10.00

10.00-10.15

10.15-10.45

10.45-11.00

11.00-11.20

11.20-11.40

11.40-12.10

12.10-12.30

12.30-12.40

12.40-13.40

13.40-14.10

14.10-14.40

14.40-14.50

14.50-15.10

15.10-15.30

15.30-15.45

15.45 

Registration 

Welcome & Introduction - H.L.A. Janssen

Portal hypertension: Baveno VII and beyond - Chair S. Darwish Murad

Beta blockade all patients with portal hypertension? - C. Ripoll

Statins for all patients with cirrhosis? - R. Maan 

Treatment of hepatic encephalopathy beyond lactulose - J.G. Langendonk

Secondary prophylaxis for SBP with noroxin or rifaximin - R.B. Takkenberg

Discussion 

Coffee break

State of the art lectures part 1 - Chair M.J. Sonneveld

Porto-sinusoidal vascular disorder: a new name for an old disease - P.E. Ratou

When to start and when to stop nucleo(s)tide analogues in chronic hepatitis B - H.L.A. Janssen

Discussion

Lunch

State of the art lectures part 2 - Chair R.J. de Knegt

Steroids in alcoholic hepatitis: yes, no or with antibiotics? - A. Louvet

New pharmacological therapies for NAFLD/NASH, all diabetics with NASH on GLP-1? - S. Francque

Discussion

Liver tumors - Chair R.A. de Man

HCC surveillance; imaging, AFP and beyond - D. Sprengers

Liver transplantation for perihilar cholangiocarcinoma: indication and outcome - R.J. Porte

Discussion and closing remarks - H.L.A. Janssen

Drinks